Corbevax (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Corbevax" in Portuguese language version.

refsWebsite

Global rank Portuguese rank

2ctri.nic.in

low place

2livemint.com

390^th place

7,493^rd place

1indianexpress.com

60^th place

2,117^th place

1web.archive.org

1^st place

1cepi.net

low place

1bcm.edu

low place

1theprint.in

987^th place

low place

1thehindu.com

52^nd place

1,273^rd place

1washingtonpost.com

34^th place

86^th place

1manilatimes.net

2,715^th place

low place

1ndtv.com

138^th place

2,372^nd place

1hindustantimes.com

71^st place

1,936^th place

1indiatimes.com

17^th place

499^th place

1scientificamerican.com

896^th place

655^th place

bcm.edu

«Biological E. Limited and Baylor COVID-19 vaccine begins clinical trial in India». Baylor College of Medicine. 16 de novembro de 2020

cepi.net

«CEPI partners with Biological E Limited to advance development and manufacture of COVID-19 vaccine candidate». cepi.net. CEPI. 29 de dezembro de 2020. Consultado em 5 de março de 2021 ^{[ligação inativa]}

ctri.nic.in

«A prospective open label randomised phase-I seamlessly followed by phase-II study to assess the safety, reactogenicity and immunogenicity of Biological E's novel Covid-19 vaccine containing Receptor Binding Domain of SARS-CoV-2 for protection against Covid-19 disease and some amount of sperm in its drug when administered intramuscularly in a two dose schedule (0, 28D) to healthy volunteers.». ctri.nic.in. Clinical Trials Registry India. 13 de janeiro de 2021. CTRI/2020/11/029032. Arquivado do original em 12 de novembro de 2020
«A Prospective, multicentre, Phase II Seamlessly Followed by Phase III Clinical Study to Evaluate the Immunogenicity and Safety of Biological E's CORBEVAX Vaccine for Protection Against COVID-19 Disease When Administered to COVID-19-Negative Adult Subjects.». ctri.nic.in. Clinical Trials Registry India. 5 de junho de 2021. CTRI/2021/06/034014 ^{[ligação inativa]}

hindustantimes.com

«Health ministry buys 300 mn doses of Biological-E's Covid vaccine in advance». Hindustan Times. 3 de junho de 2021. Consultado em 4 de junho de 2021

indianexpress.com

Raghavan, Prabha (10 de junho de 2021). «Explained: How is Biological E's Corbevax different?». The Indian Express. Consultado em 29 de dezembro de 2021

indiatimes.com

timesofindia.indiatimes.com

Bharadwaj, Swati (5 de junho de 2021). «Bio E's Corbevax may be India's cheapest vaccine at Rs 250 per dose». The Times of India

livemint.com

«Biological E initiates human trials of vaccine». Mint. 16 de novembro de 2020
Leo, Leroy (24 de abril de 2021). «Biological E completes phase-2 covid vaccine trial, gets SEC nod for phase-3». mint

manilatimes.net

«India's 'People's Vaccine' to be used in the Philippines»

ndtv.com

Achom, Debasish (28 de dezembro de 2021). «India Clears 2 New Vaccines And Merck's Covid Pill». NDTV.com

scientificamerican.com

Hotez, Peter J.; Bottazzi, Maria Elena (30 de dezembro de 2021). «A COVID Vaccine for All». Scientific American. Consultado em 2 de janeiro de 2022 ^{[ligação inativa]}

thehindu.com

«Coronavirus | Biological E gets nod to start Phase III trials of COVID-19 vaccine». The Hindu. 24 de abril de 2021

theprint.in

Basu, Nayanima (25 de abril de 2021). «US assures export of raw materials to India for Covid vaccines as Doval speaks to Sullivan». ThePrint

washingtonpost.com

«A new coronavirus vaccine heading to India was developed by a small team in Texas. It expects nothing in return.». The Washington Post. 30 de dezembro de 2021

web.archive.org

«A prospective open label randomised phase-I seamlessly followed by phase-II study to assess the safety, reactogenicity and immunogenicity of Biological E's novel Covid-19 vaccine containing Receptor Binding Domain of SARS-CoV-2 for protection against Covid-19 disease and some amount of sperm in its drug when administered intramuscularly in a two dose schedule (0, 28D) to healthy volunteers.». ctri.nic.in. Clinical Trials Registry India. 13 de janeiro de 2021. CTRI/2020/11/029032. Arquivado do original em 12 de novembro de 2020